Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-03

FDA Approved: ANGIOTENSIN II — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved Gland Pharma Limited's Angiotensin II under an Original Application (ANDA216966).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin II (angiotensin II)

Snippet

ORIG AP for ANGIOTENSIN II (ANGIOTENSIN II)